1. Home
  2. HIHO vs SNGX Comparison

HIHO vs SNGX Comparison

Compare HIHO & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Highway Holdings Limited

HIHO

Highway Holdings Limited

N/A

Current Price

$0.90

Market Cap

4.1M

Sector

Industrials

ML Signal

N/A

Logo Soligenix Inc.

SNGX

Soligenix Inc.

N/A

Current Price

$0.37

Market Cap

8.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HIHO
SNGX
Founded
1990
1987
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1M
8.2M
IPO Year
2002
2006

Fundamental Metrics

Financial Performance
Metric
HIHO
SNGX
Price
$0.90
$0.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
31.6K
★ 200.0K
Earning Date
07-20-2026
11-06-2026
Dividend Yield
★ 11.10%
N/A
EPS Growth
N/A
★ 57.03
EPS
★ N/A
N/A
Revenue
N/A
★ $119,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.60
$0.28
52 Week High
$2.21
$1.97

Technical Indicators

Market Signals
Indicator
HIHO
SNGX
Relative Strength Index (RSI) 46.72 40.65
Support Level $0.86 $0.35
Resistance Level $0.93 $0.41
Average True Range (ATR) 0.05 0.01
MACD 0.00 -0.00
Stochastic Oscillator 30.18 14.44

Price Performance

Historical Comparison
HIHO
SNGX

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. Along with its subsidiaries, it operates as a fully integrated manufacturer of high-quality metal, plastic, electric and electronic components, subassemblies, and finished products for OEMs and contract manufacturers. The manufacturing services offered by the group include metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. Its reportable business segments are metal stamping and mechanical OEM operations, which derive maximum revenue, and electric OEM operations. Geographically, the group generates maximum revenue from Europe, and the rest from North America, Hong Kong and China, and other Asian countries.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

Share on Social Networks: